Zentalis Pharmaceuticals, Inc. - common stock — 재무제표 (NASDAQ:ZNTL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 365.56 M454.51 M539.31 M551.69 M430.34 M288.97 M 총 부채 32.18 M90.03 M105.29 M114.3 M93.15 M72.76 M 자본금 총액 333.38 M364.48 M434.02 M437.39 M337.19 M216.2 M 총 부채 및 주주자본 365.56 M454.51 M539.31 M551.69 M430.34 M288.97 M 총부채 —————— 순부채 ——————

뉴스

What's Behind The Surge In Zentalis Stock? - Zentalis Pharmaceuticals (NASDAQ:ZNTL)

웰스 파고, 젠탈리스 주식에 ’동일 비중’ 투자의견 제시, 목표가 5달러

Wells Fargo assumes coverage on Zentalis stock with $5 target

Zentalis Pharma CEO Eastland sells $21k in shares

Zentalis Pharma CMO Bruns sells $7998 in stock

젠탈리스 제약 PAO, 980만원 상당 주식 매각

Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)

젠탈리스 파마슈티컬 주가 목표가, Leerink Partners에서 2달러로 하향 조정

Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners

Zentalis to present azenosertib data at cancer therapeutics conference

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting